AI assistant
Sending…
Mural Oncology PLC — Director's Dealing 2023
Nov 15, 2023
14932_dirs_2023-11-15_de6fd91b-f4bc-494b-959d-d6032ed112e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mural Oncology plc (MURA)
CIK: 0001971543
Period of Report: 2023-11-15
Reporting Person: Keson-Brookes Maiken (N/A)
More from Mural Oncology PLC
Major Shareholding Notification
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Dec 9
Regulatory Filings
2025
Dec 5
Regulatory Filings
2025
Dec 5
Regulatory Filings
2025
Dec 5
Regulatory Filings
2025
Dec 5
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 5